Literature DB >> 23697618

Is 24-hour intraocular pressure monitoring necessary in glaucoma?

Kaweh Mansouri1, Robert N Weinreb, Felipe A Medeiros.   

Abstract

Although intraocular pressure (IOP) is the only treatable risk factor for glaucoma, its 24-hour behavior is poorly understood. Conflicting information is available in the literature with regard to the importance and predictive value of IOP peaks and fluctuations on the risk of glaucoma development and progression. This may be secondary to lack of prospective studies designed to address this issue. This article critically reviews the current evidence for the importance of 24-h IOP measurements in glaucoma and discusses shortcomings of current methods to assess 24-h IOP data, drawing attention to new developments in this field.

Entities:  

Mesh:

Year:  2013        PMID: 23697618      PMCID: PMC3804261          DOI: 10.3109/08820538.2013.771201

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  63 in total

1.  Dampening of diurnal intraocular pressure fluctuation by combined trabeculotomy and sinusotomy in eyes with open-angle glaucoma.

Authors:  Masato Matsuoka; Akira Ando; Keizo Minamino; Kayako Matsuyama; Chieko Shima; Miyo Matsumura; Tetsuya Nishimura
Journal:  J Glaucoma       Date:  2013 Apr-May       Impact factor: 2.503

2.  Wireless contact lens sensor for intraocular pressure monitoring: assessment on enucleated pig eyes.

Authors:  Matteo Leonardi; Elie M Pitchon; Arnaud Bertsch; Philippe Renaud; André Mermoud
Journal:  Acta Ophthalmol       Date:  2008-11-12       Impact factor: 3.761

3.  24-hour IOP telemetry in the nonhuman primate: implant system performance and initial characterization of IOP at multiple timescales.

Authors:  J Crawford Downs; Claude F Burgoyne; William P Seigfreid; Juan F Reynaud; Nicholas G Strouthidis; Verney Sallee
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-21       Impact factor: 4.799

4.  Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for normal-tension glaucoma.

Authors:  Jaewan Choi; Kyung Hoon Kim; Jinho Jeong; Hyun-Soo Cho; Chang Hwan Lee; Michael S Kook
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-01       Impact factor: 4.799

5.  Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma.

Authors:  Yaniv Barkana; Sarah Anis; Jeffrey Liebmann; Celso Tello; Robert Ritch
Journal:  Arch Ophthalmol       Date:  2006-06

6.  Sequential office pressure measurements in the management of glaucoma.

Authors:  Nanny Collaer; Thierry Zeyen; Joseph Caprioli
Journal:  J Glaucoma       Date:  2005-06       Impact factor: 2.503

7.  Beta-Zone parapapillary atrophy and the velocity of glaucoma progression.

Authors:  Christopher C Teng; Carlos Gustavo V De Moraes; Tiago S Prata; Celso Tello; Robert Ritch; Jeffrey M Liebmann
Journal:  Ophthalmology       Date:  2010-02-04       Impact factor: 12.079

8.  The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1998-10       Impact factor: 5.258

9.  The probability of blindness from open-angle glaucoma.

Authors:  M G Hattenhauer; D H Johnson; H H Ing; D C Herman; D O Hodge; B P Yawn; L C Butterfield; D T Gray
Journal:  Ophthalmology       Date:  1998-11       Impact factor: 12.079

10.  Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes.

Authors:  John H K Liu; Xiaoyan Zhang; Daniel F Kripke; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-04       Impact factor: 4.799

View more
  15 in total

1.  Effect of glaucoma medications on 24-hour intraocular pressure-related patterns using a contact lens sensor.

Authors:  Kaweh Mansouri; Felipe A Medeiros; Robert N Weinreb
Journal:  Clin Exp Ophthalmol       Date:  2015-08-16       Impact factor: 4.207

2.  Comparison of ICare and IOPen vs Goldmann applanation tonometry according to international standards 8612 in glaucoma patients.

Authors:  Milena Pahlitzsch; Jeanette Brünner; Johannes Gonnermann; Anna-Karina B Maier; Necip Torun; Eckart Bertelmann; Matthias Kj Klamann
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

3.  Correlations between Corneal Biomechanics and Glaucoma Severity in Patients with Primary Open Angle Glaucoma.

Authors:  Dana Dascalescu; Catalina Corbu; Mihaela Constantin; Miruna Cristea; Catalina Ionescu; Miruna Cioboata; Liliana Voinea
Journal:  Maedica (Bucur)       Date:  2015-09

4.  Corneoscleral stiffening increases IOP spike magnitudes during rapid microvolumetric change in the eye.

Authors:  Keyton Clayson; Xueliang Pan; Elias Pavlatos; Ryan Short; Hugh Morris; Richard T Hart; Jun Liu
Journal:  Exp Eye Res       Date:  2017-08-30       Impact factor: 3.467

5.  Automated Detection and Quantification of Circadian Eye Blinks Using a Contact Lens Sensor.

Authors:  Christophe Gisler; Antonio Ridi; Jean Hennebert; Robert N Weinreb; Kaweh Mansouri
Journal:  Transl Vis Sci Technol       Date:  2015-01-22       Impact factor: 3.283

6.  Home Self-tonometry Trials Compared with Clinic Tonometry in Patients with Glaucoma.

Authors:  Elyse J McGlumphy; Aleksandra Mihailovic; Pradeep Y Ramulu; Thomas V Johnson
Journal:  Ophthalmol Glaucoma       Date:  2021-04-09

7.  Efficacy of a contact lens sensor for monitoring 24-h intraocular pressure related patterns.

Authors:  Kaweh Mansouri; Robert N Weinreb; John H K Liu
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

8.  Detecting IOP Fluctuations in Glaucoma Patients.

Authors:  Brenda Nuyen; Kaweh Mansouri
Journal:  Open Ophthalmol J       Date:  2016-02-29

Review 9.  Noninvasive intraocular pressure monitoring: current insights.

Authors:  Stefan De Smedt
Journal:  Clin Ophthalmol       Date:  2015-07-30

10.  Individualized Significance of 24-Hour Intraocular Pressure Curves for Therapeutic Decisions in Primary Chronic Open-Angle Glaucoma Patients.

Authors:  Mael Lever; Jan Darius Unterlauft; Christian Halfwassen; Nikolaos E Bechrakis; Anke Manthey; Michael R R Böhm
Journal:  Clin Ophthalmol       Date:  2020-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.